Linh Nguyen
Family Medicine · Arlington, TXNPI 1598128548
Payments from drug & device makers
Across 250 payments — averaging $16.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$907
- Lilly USA, LLC$661
- Novo Nordisk$422
- AstraZeneca$330
- Boehringer Ingelheim$319
- Bayer$273
- plus $1K from 20 others
What the payments were for
- Food & beverage$4,167100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 65 | $907 |
| Lilly USA, LLC | 37 | $661 |
| Novo Nordisk | 25 | $422 |
| AstraZeneca | 20 | $330 |
| Boehringer Ingelheim | 21 | $319 |
| Bayer | 15 | $273 |
| Exact Sciences | 9 | $199 |
| Abbott | 7 | $160 |
| Astellas Pharma US Inc | 7 | $126 |
| GSK | 5 | $101 |
| Johnson & Johnson | 7 | $92 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $82 |
| Amarin Pharma, Inc. | 4 | $82 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| Kowa Pharmaceuticals America, Inc. | 4 | $61 |
| Idorsia Pharmaceuticals US Inc | 3 | $53 |
| Sumitomo Pharma America, Inc. | 3 | $45 |
| Phathom Pharmaceuticals, Inc. | 2 | $40 |
| Biotronik NRO, Inc. | 1 | $28 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Merck | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Echosens North America, Inc. | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Amgen | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
How this compares
$4,167 in reported general payments places this provider in the 80th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 24 | $39,354 |
| OzempicSemaglutide | 24 | $30,956 |
| TrulicityDulaglutide | 22 | $27,709 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 24 | $23,251 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $2,078 |
| Levothyroxine Sodium | 143 | $1,715 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 54 | $1,484 |
| Atorvastatin Calcium | 200 | $1,364 |
| Gabapentin | 103 | $1,193 |
| Methylprednisolone | 126 | $1,149 |
| Losartan Potassium | 81 | $748 |
| Metformin Hcl | 83 | $744 |
| Esomeprazole Magnesium | 19 | $674 |
| Bupropion XlBupropion Hcl | 24 | $640 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 11 | $620 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $319 | $39,35424 claims |
| Novo NordiskOzempic | $422 | $30,95624 claims |
| Lilly USA, LLCTrulicity | $661 | $27,70922 claims |
| GSKTrelegy Ellipta | $101 | $23,25124 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Arlington
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
- Bonnie ColvilleHouston$19.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.